INOZYME PHARMA INC. -
5.2100
07-October-24 14:59:31
15 minutes delayed
Stocks
+0.0400
+0.77%
Today's range
5.1200 - 5.2800
ISIN
N/A
Source
NASDAQ
-
07 Oct 2024 07:30:17 By Nasdaq GlobeNewswire
-
26 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate at the 2024 Wells Fargo Healthcare Conference
29 Aug 2024 07:30:23 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Second Quarter 2024 Financial Results and Provides Business Highlights
06 Aug 2024 07:30:00 By Nasdaq GlobeNewswire
-
25 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency
02 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
-
21 Jun 2024 12:00:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the Jefferies Global Healthcare Conference
30 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
23 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference
08 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
07 May 2024 07:30:44 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 May 2024 07:30:02 By Nasdaq GlobeNewswire
-
08 Apr 2024 05:30:35 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Apr 2024 17:00:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference
02 Apr 2024 07:30:03 By Nasdaq GlobeNewswire
-
26 Mar 2024 07:30:42 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights
12 Mar 2024 07:30:16 By Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference
26 Feb 2024 07:30:00 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Feb 2024 07:30:48 By Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Dec 2023 07:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >